Age-Related Morbidity and Mortality among Patients with COVID-19

다국어 초록 (Multilingual Abstract)

On March 11, 2020, the World Health Organization declared coronavirus disease (COVID-19), caused by the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a pandemic. During the COVID-19 pandemic, an age-associated vulnerability in the burden of disease has been uncovered. Understanding the spectrum of illness and the pathogenic mechanism of the disease in a vulnerable population is critical, especially during the pandemic. Herein, we reviewed published COVID-19 epidemiology data from several countries to identify any consistent trends in the relationship between age and COVID-19-associated morbidity or mortality. We also reviewed the literature for studies explaining the difference in the host response to SARS-CoV-2 infection according to age. The insights from these data will be useful in determining the treatment policies and preventive measures of COVID-19.

참고문헌 (Reference)

1 Cristiani L, "Will children reveal their secret? The coronavirus dilemma" 55 : 2000749-, 2020

2 Kim DH, "Understanding and interpretation of case fatality rate of coronavirus disease 2019" 35 : e137-, 2020

3 Fu Y, "Understanding SARS-CoV-2-mediated inflammatory responses : from mechanisms to potential therapeutic tools" 1-6, 2020

4 Tay MZ, "The trinity of COVID-19 : immunity, inflammation and intervention" 20 : 363-374, 2020

5 Bouvier NM, "The future of influenza vaccines: a historical and clinical perspective" 6 : 58-, 2018

6 The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, "The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) - China, 2020" 2 : 113-122, 2020

7 Korea Centers for Disease Control and Prevention (KCDC), "Status of COVID-19 in Korea"

8 Stockman LJ, "Severe acute respiratory syndrome in children" 26 : 68-74, 2007

9 Leung CW, "Severe acute respiratory syndrome among children" 113 : e535-e543, 2004

10 DeBiasi RL, "Severe COVID-19 in children and young adults in the Washington, DC metropolitan region" 2020

11 Cao Q, "SARS-CoV-2 infection in children : transmission dynamics and clinical characteristics" 119 : 670-673, 2020

12 Nikolich-Zugich J, "SARS-CoV-2 and COVID-19 in older adults : what we may expect regarding pathogenesis, immune responses, and outcomes" 42 : 505-514, 2020

13 de Wit E, "SARS and MERS : recent insights into emerging coronaviruses" 14 : 523-534, 2016

14 Leung C, "Risk factors for predicting mortality in elderly patients with COVID-19 : a review of clinical data in China" 188 : 111255-, 2020

15 World Health Organization (WHO), "Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19)"

16 Vaduganathan M, "Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19" 382 : 1653-1659, 2020

17 Gorse GJ, "Prevalence of antibodies to four human coronaviruses is lower in nasal secretions than in serum" 17 : 1875-1880, 2010

18 Zhang ZJ, "Novel coronavirus infection in newborn babies zzzzzz28 days in China" 55 : 2000697-, 2020

19 Wei M, "Novel coronavirus infection in hospitalized infants under 1 year of age in China" 323 : 1313-1314, 2020

20 World Health Organization (WHO), "Multisystem inflammatory syndrome in children and adolescents with COVID-19"

21 Tilocca B, "Molecular basis of COVID-19 relationships in different species : a one health perspective" 22 : 218-220, 2020

22 Mitroulis I, "Modulation of myelopoiesis progenitors is an integral component of trained immunity" 172 : 147-161.e12, 2018

23 Thabet F, "Middle East respiratory syndrome coronavirus in children" 36 : 484-486, 2015

24 Memish ZA, "Middle East respiratory syndrome coronavirus disease in children" 33 : 904-906, 2014

25 Bartenfeld M, "Middle East respiratory syndrome coronavirus and children" 56 : 187-189, 2017

26 Tosato F, "Lymphocytes subsets reference values in childhood" 87 : 81-85, 2015

27 Negro F, "Is antibody-dependent enhancement playing a role in COVID-19 pathogenesis?" 150 : w20249-, 2020

28 Bonafè M, "Inflamm-aging: Why older men are the most susceptible to SARS-CoV-2 complicated outcomes" 2020

29 김탁, "Improving Preparedness for and Response to Coronavirus Disease 19 (COVID-19) in Long-Term Care Hospitals in Korea" 대한감염학회 52 (52): 133-141, 2020

30 Riphagen S, "Hyperinflammatory shock in children during COVID-19 pandemic" 395 : 1607-1608, 2020

31 Prill MM, "Human coronavirus in young children hospitalized for acute respiratory illness and asymptomatic controls" 31 : 235-240, 2012

32 Koo Bo Kyung, "Glove-Wall System for Respiratory Specimen Collection and COVID-19 Mass Screening" 대한감염학회 52 (52): 219-221, 2020

33 The Centre for Evidence-Based Medicine develops, promotes and disseminates better evidence for healthcare (CEBM), "Global covid-19 case fatality rates"

34 Hu X, "Factors associated with negative conversion of viral RNA in patients hospitalized with COVID-19" 728 : 138812-, 2020

35 Oliva J, "Estimating the burden of seasonal influenza in Spain from surveillance of mild and severe influenza disease, 2010-2016" 12 : 161-170, 2018

36 Dong Y, "Epidemiology of COVID-19 among children in China" 145 : e20200702-, 2020

37 Bi Q, "Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study" 2020

38 Istituto Superiore di Sanità, "Epidemia COVID-19"

39 Glowacka I, "Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63" 84 : 1198-1205, 2010

40 Kim YJ, "Defining association between COVID-19 and the multisystem inflammatory syndrome in children through the pandemic" 35 : e204-, 2020

41 Office for National Statics, "Deaths registered weekly in England and Wales, provisional: week ending 8 May 2020"

42 Ferrario CM, "Counterregulatory actions of angiotensin-(1-7)" 30 : 535-541, 1997

43 NYC Department of Health and Mental Hygiene, "Coronavirus-data"

44 Zimmermann P, "Coronavirus infections in children including COVID-19 : an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children" 39 : 355-368, 2020

45 World Health Organization (WHO), "Coronavirus disease (COVID-2019) situation report -110"

46 Castle SC, "Clinical relevance of age-related immune dysfunction" 31 : 578-585, 2000

47 Leung C, "Clinical features of deaths in the novel coronavirus epidemic in China" 30 : e2103-, 2020

48 Liu K, "Clinical features of COVID-19 in elderly patients : a comparison with young and middle-aged patients" 80 : e14-e18, 2020

49 Zhou F, "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China : a retrospective cohort study" 395 : 1054-1062, 2020

50 von der Beck D, "Characteristics and outcomes of a cohort hospitalized for pandemic and seasonal influenza in Germany based on nationwide inpatient data" 12 : e0180920-, 2017

51 Statistics Korea, "Cause-of-death statistics in 2018"

52 COVID-19 National Incident Room Surveillance Team, "COVID-19, Australia: epidemiology report 6 (Reporting week ending 19:00 AEDT 7 March 2020)" 44-, 2020

53 Cesari M, "COVID-19 in Italy : ageism and decision making in a pandemic" 21 : 576-577, 2020

54 Natale A, "COVID-19 cases and case fatality rate by age. Knowledge for policy"

55 Jones VG, "COVID-19 and Kawasaki disease : novel virus and novel case" 10 : 537-540, 2020

56 Kadkhoda K, "COVID-19 : an immunopathological view" 5 : e00344-20, 2020

57 Sodhi CP, "Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg9 bradykinin/ BKB1R axis and facilitates LPS-induced neutrophil infiltration" 314 : L17-L31, 2018

58 Lee PI, "Are children less susceptible to COVID-19?" 53 : 371-372, 2020

59 Takada A, "Antibody-dependent enhancement of viral infection : molecular mechanisms and in vivo implications" 13 : 387-398, 2003

60 Tikellis C, "Angiotensin-converting enzyme 2(ACE2)Is a key modulator of the renin angiotensin system in health and disease" 2012 : 256294-, 2012

61 Imai Y, "Angiotensin-converting enzyme 2 protects from severe acute lung failure" 436 : 112-116, 2005

62 Yu P, "Age-related rhesus macaque models of COVID-19" 3 : 93-97, 2020

63 Xie X, "Age-and gender-related difference of ACE2 expression in rat lung" 78 : 2166-2171, 2006

64 Greer AL, "Age, influenza pandemics and disease dynamics" 138 : 1542-1549, 2010

65 Monto AS, "Acute respiratory illness in an American community. The Tecumseh study" 227 : 164-169, 1974

66 Kam KQ, "A well infant with coronavirus disease 2019 (COVID-19) with high viral load" 2020

67 Promislow DEL, "A geroscience perspective on COVID-19 mortality" 2020

68 Taubenberger JK, "1918 Influenza : the mother of all pandemics" 12 : 15-22, 2006